# Saruparib (AZD5305) vs Placebo in Men With Metastatic Castration-Sensitive Prostate Cancer Receiving Physician's Choice New Hormonal Agents

> clinical trial · VERIFIED · 2026-07-29

Status: ACTIVE_NOT_RECRUITING · Sponsor: AstraZeneca · Condition: Metastatic Castration-Sensitive Prostate Cancer

- Company: AstraZeneca
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT06120491

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.